Ibuprofen

Description

Ibuprofen is the active ingredient in this formulation, presented in a dosage form of tablets. Each tablet contains a strength of 200 mg of ibuprofen. The product is packaged in a quantity of 50 tablets.

Uses and Indications

This drug is indicated for the temporary relief of minor aches and pains associated with various conditions, including headache, muscular aches, minor pain of arthritis, toothache, backache, the common cold, and menstrual cramps. Additionally, it is indicated for the temporary reduction of fever.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

The medication should be administered according to the following guidelines to ensure safety and efficacy.

For adults and children aged 12 years and older, the recommended dosage is 1 tablet every 4 to 6 hours as needed while symptoms persist. In cases where pain or fever does not adequately respond to 1 tablet, a maximum of 2 tablets may be taken. It is imperative that the total dosage does not exceed 6 tablets within a 24-hour period, unless otherwise directed by a healthcare professional.

For children under 12 years of age, it is advised to consult a doctor for appropriate dosing recommendations.

Healthcare professionals should emphasize the importance of using the smallest effective dose and adhering strictly to the prescribed dosage to avoid potential adverse effects.

Contraindications

Use of this product is contraindicated in patients with a history of allergic reactions to ibuprofen or any other pain reliever or fever reducer. Additionally, it should not be administered immediately before or after heart surgery due to potential complications associated with surgical recovery.

Warnings and Precautions

Ibuprofen may induce severe allergic reactions, particularly in individuals with a known allergy to aspirin. Symptoms indicative of an allergic response may include hives, facial swelling, asthma (wheezing), shock, skin reddening, rash, and blisters. In the event of an allergic reaction, it is imperative to discontinue use immediately and seek medical assistance.

The use of ibuprofen, a nonsteroidal anti-inflammatory drug (NSAID), carries a significant risk of severe stomach bleeding. This risk is notably elevated in certain populations, including individuals aged 60 years or older, those with a history of stomach ulcers or bleeding disorders, and patients concurrently using anticoagulants or steroid medications. Additionally, the risk increases for individuals taking other NSAIDs, whether prescription or over-the-counter, such as aspirin, ibuprofen, or naproxen. Consumption of three or more alcoholic beverages daily while using this product further heightens the likelihood of gastrointestinal complications. It is crucial to adhere strictly to the recommended dosage and duration of use to mitigate these risks.

Healthcare professionals should advise patients to discontinue use and seek medical attention if they experience any signs of stomach bleeding, which may manifest as feeling faint, vomiting blood, having bloody or black stools, or experiencing persistent stomach pain. Other concerning symptoms include indications of heart problems or stroke, such as chest pain, difficulty breathing, unilateral weakness, slurred speech, leg swelling, worsening pain lasting more than 10 days, fever persisting beyond three days, redness or swelling in the affected area, or the emergence of any new symptoms. Regular monitoring and assessment of these parameters are essential for ensuring patient safety during ibuprofen therapy.

Side Effects

Patients may experience a range of adverse reactions associated with the use of ibuprofen, which can be categorized by seriousness and frequency.

Severe allergic reactions have been reported, particularly in individuals with a known allergy to aspirin. Symptoms of such reactions may include hives, facial swelling, asthma (wheezing), shock, skin reddening, rash, and blisters. Patients should seek immediate medical attention if they experience any of these symptoms.

The use of ibuprofen, as a nonsteroidal anti-inflammatory drug (NSAID), carries a warning for the potential risk of severe stomach bleeding. This risk is heightened in patients who are 60 years of age or older, have a history of stomach ulcers or bleeding problems, are taking anticoagulants or steroid medications, consume three or more alcoholic drinks daily while using the product, or exceed the recommended dosage or duration of use. Patients should discontinue use and consult a healthcare provider if they experience signs of stomach bleeding, which may include feeling faint, vomiting blood, having bloody or black stools, or experiencing persistent stomach pain.

Additional serious adverse reactions may include symptoms indicative of heart problems or stroke, such as chest pain, difficulty breathing, weakness on one side of the body, slurred speech, and leg swelling. Patients should also be aware that pain persisting for more than 10 days, fever lasting more than three days, or the appearance of new symptoms warrants medical evaluation.

Common adverse reactions may include gastrointestinal discomfort, and patients with a history of stomach problems, high blood pressure, heart disease, liver cirrhosis, kidney disease, or asthma should consult a healthcare provider before using ibuprofen. It is also advisable for patients taking aspirin for cardiovascular protection to discuss their use of ibuprofen with a healthcare professional, as it may diminish the cardioprotective effects of aspirin.

In summary, while ibuprofen can be effective for pain relief and fever reduction, patients should be vigilant for serious adverse reactions and consult healthcare providers as necessary to ensure safe use.

Drug Interactions

Ibuprofen may diminish the cardioprotective effects of aspirin when used for the prevention of heart attack or stroke. It is advisable to avoid concurrent use of ibuprofen and aspirin for patients who are relying on aspirin for cardiovascular protection. Monitoring for efficacy of aspirin therapy is recommended in patients who require both medications.

Packaging & NDC

Below are the non-prescription pack sizes of Ibuprofen 200mg. Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients under 12 years of age should consult a healthcare professional before use. For adolescents aged 12 years and older, the recommended dosage is 1 tablet every 4 to 6 hours as needed while symptoms persist. In cases where pain or fever does not adequately respond to 1 tablet, a dose of 2 tablets may be administered. It is important to note that the maximum dosage should not exceed 6 tablets within a 24-hour period, unless otherwise directed by a healthcare provider.

Geriatric Use

Elderly patients, particularly those aged 60 years and older, may have an increased risk of stomach bleeding. It is essential for healthcare providers to exercise caution when prescribing medications that may exacerbate this risk in this population.

Monitoring for signs of gastrointestinal bleeding is advised, and dosage adjustments may be necessary based on the individual patient's health status and concurrent medications. Careful assessment of the benefits and risks of treatment in geriatric patients is crucial to ensure their safety and well-being.

Pregnancy

Pregnant patients should consult a healthcare professional before using this medication, particularly if they are in the later stages of pregnancy or breastfeeding. It is especially important to avoid the use of ibuprofen during the last trimester unless specifically directed by a physician, as it may pose risks to the developing fetus and lead to complications during delivery. Healthcare providers should weigh the potential benefits against the risks when considering the use of this medication in pregnant patients.

Lactation

Lactating mothers are advised to consult a health professional before using this medication while breastfeeding. It is particularly important to avoid the use of ibuprofen during the last three months of pregnancy unless specifically directed by a healthcare provider, as it may pose risks to the unborn child or lead to complications during delivery. There is no specific data provided regarding the excretion of this medication in breast milk or its effects on breastfed infants. Therefore, caution is recommended when considering its use in lactating individuals.

Renal Impairment

There is no specific information available regarding dosage adjustments, special monitoring, or safety considerations for patients with renal impairment. Healthcare professionals should exercise caution when prescribing to patients with reduced kidney function, as the absence of detailed guidance necessitates careful clinical judgment. Regular monitoring of renal function may be advisable in these patients to ensure safety and efficacy.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

Overdosage of ibuprofen can lead to significant health risks and serious harm. Healthcare professionals should be aware of the potential symptoms and recommended actions in the event of an overdose.

Symptoms of Overdose Patients experiencing an ibuprofen overdose may present with a range of symptoms, including nausea, vomiting, stomach pain, drowsiness, headache, and confusion. These symptoms can vary in severity and may require prompt medical evaluation.

Recommended Actions In the event of an overdose, it is crucial to seek immediate medical attention. Healthcare providers should advise patients or caregivers to contact a Poison Control Center for further guidance. Timely intervention is essential to mitigate the potential adverse effects associated with ibuprofen overdosage.

Nonclinical Toxicology

It is especially important not to use ibuprofen during the last three months of pregnancy unless specifically directed by a healthcare professional, as it may lead to complications for the unborn child or during delivery. No specific non-teratogenic effects have been identified in the available data. Additionally, there are no detailed findings regarding nonclinical toxicology or animal pharmacology and toxicology provided in the current information.

Postmarketing Experience

Postmarketing experience has identified a range of adverse reactions associated with the use of the product. Reports of allergic reactions have included hives, facial swelling, asthma (wheezing), shock, skin reddening, rash, and blisters. Severe gastrointestinal events, such as nausea, vomiting, diarrhea, constipation, and abdominal pain, have also been documented.

Particular attention has been drawn to severe stomach bleeding, especially in individuals aged 60 years or older, those with a history of stomach ulcers or bleeding problems, patients taking blood thinners or steroids, individuals consuming three or more alcoholic drinks daily, and those using other nonsteroidal anti-inflammatory drugs (NSAIDs).

Cardiovascular events, including myocardial infarction and stroke, have been reported. Additionally, renal adverse events such as acute renal failure and interstitial nephritis have been noted. Hepatic adverse events, including elevated liver enzymes and hepatitis, have also been documented.

Skin reactions, including serious conditions such as Stevens-Johnson syndrome and toxic epidermal necrolysis, have been reported. Central nervous system effects, including dizziness, headache, and drowsiness, have been observed in postmarketing surveillance.

Patient Counseling

Healthcare providers should advise patients to seek immediate medical assistance or contact a Poison Control Center in the event of an overdose. It is crucial to inform patients that they should not use this medication if they have a history of allergic reactions to ibuprofen or any other pain reliever or fever reducer. Additionally, patients should be cautioned against using this product right before or after undergoing heart surgery.

Patients must be instructed to stop using the medication and consult a doctor if they experience any signs of stomach bleeding, which may include feeling faint, vomiting blood, having bloody or black stools, or experiencing persistent stomach pain. They should also be aware of symptoms indicative of heart problems or stroke, such as chest pain, difficulty breathing, weakness on one side of the body, slurred speech, leg swelling, worsening pain lasting more than 10 days, fever that worsens or lasts more than 3 days, redness or swelling in the painful area, or the emergence of any new symptoms.

When using this product, patients should be advised to take it with food or milk if they experience stomach upset. It is important for patients to consult a doctor before use if they have experienced problems or serious side effects from pain relievers or fever reducers in the past. They should also be encouraged to seek medical advice if the warning regarding stomach bleeding applies to them, or if they have a history of stomach issues, such as heartburn.

Furthermore, patients with high blood pressure, heart disease, liver cirrhosis, kidney disease, asthma, or a history of stroke should be advised to consult a doctor before using this medication. Those taking diuretics or aspirin for heart attack or stroke should also seek guidance from a healthcare professional, as ibuprofen may diminish the effectiveness of aspirin. Lastly, patients under a doctor's care for any serious condition or those taking other medications should be encouraged to discuss their use of this product with a doctor or pharmacist.

Storage and Handling

The product is supplied in various package configurations, with specific NDC numbers available upon request. It should be stored at a controlled room temperature of 20-25°C (68-77°F). Care should be taken to avoid exposure to high humidity and excessive heat, with temperatures not exceeding 40°C (104°F). Proper storage conditions are essential to maintain the integrity and efficacy of the product.

Additional Clinical Information

No further data are available.

Drug Information (PDF)

This file contains official product information for Ibuprofen 200mg, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)